Table 1
Open in new tab

Baseline clinical characteristics of the study population

Total population (n = 463)
Demographic data, n (%)
 Male gender349 (75)
 Age (years)62 ± 11
Clinical data, n (%)
 Indication ICD therapy
  Primary prevention346 (75)
  Secondary prevention117 (25)
 NYHA class
  II129 (28)
  III334 (72)
 Left ventricular ejection fraction (%)24 ± 7
 QRS duration (ms)165 ± 30
 Creatinine (mg/dL)1.35 ± 0.70
 Ischaemic aetiology233 (50)
 History of myocardial infarction200 (43)
 History of bypass surgery95 (21)
 Pharmacological treatment
  Amiodarone135 (29)
  Beta-blockers350 (76)
  ACE-inhibitors/ARBs423 (91)
  Diuretics388 (84)
  Digoxin117 (25)
  Statin245 (53)
Total population (n = 463)
Demographic data, n (%)
 Male gender349 (75)
 Age (years)62 ± 11
Clinical data, n (%)
 Indication ICD therapy
  Primary prevention346 (75)
  Secondary prevention117 (25)
 NYHA class
  II129 (28)
  III334 (72)
 Left ventricular ejection fraction (%)24 ± 7
 QRS duration (ms)165 ± 30
 Creatinine (mg/dL)1.35 ± 0.70
 Ischaemic aetiology233 (50)
 History of myocardial infarction200 (43)
 History of bypass surgery95 (21)
 Pharmacological treatment
  Amiodarone135 (29)
  Beta-blockers350 (76)
  ACE-inhibitors/ARBs423 (91)
  Diuretics388 (84)
  Digoxin117 (25)
  Statin245 (53)
Table 1
Open in new tab

Baseline clinical characteristics of the study population

Total population (n = 463)
Demographic data, n (%)
 Male gender349 (75)
 Age (years)62 ± 11
Clinical data, n (%)
 Indication ICD therapy
  Primary prevention346 (75)
  Secondary prevention117 (25)
 NYHA class
  II129 (28)
  III334 (72)
 Left ventricular ejection fraction (%)24 ± 7
 QRS duration (ms)165 ± 30
 Creatinine (mg/dL)1.35 ± 0.70
 Ischaemic aetiology233 (50)
 History of myocardial infarction200 (43)
 History of bypass surgery95 (21)
 Pharmacological treatment
  Amiodarone135 (29)
  Beta-blockers350 (76)
  ACE-inhibitors/ARBs423 (91)
  Diuretics388 (84)
  Digoxin117 (25)
  Statin245 (53)
Total population (n = 463)
Demographic data, n (%)
 Male gender349 (75)
 Age (years)62 ± 11
Clinical data, n (%)
 Indication ICD therapy
  Primary prevention346 (75)
  Secondary prevention117 (25)
 NYHA class
  II129 (28)
  III334 (72)
 Left ventricular ejection fraction (%)24 ± 7
 QRS duration (ms)165 ± 30
 Creatinine (mg/dL)1.35 ± 0.70
 Ischaemic aetiology233 (50)
 History of myocardial infarction200 (43)
 History of bypass surgery95 (21)
 Pharmacological treatment
  Amiodarone135 (29)
  Beta-blockers350 (76)
  ACE-inhibitors/ARBs423 (91)
  Diuretics388 (84)
  Digoxin117 (25)
  Statin245 (53)
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close